switching from compounded semaglutide to wegovy Ozempic Wegovy: Cost & Access Switching Between Semaglutide and Tirzepatide:

The key question will be durability: long-term tolerability, adherence, safety, cost, and whether these outcomes can be maintained outside highly selected trial populations

While we await dedicated cardiovascular outcomes trials for Retatrutide, I believe the constellation of metabolic improvements points strongly toward cardioprotection

This 17-country phase 2 double-blind placebo-controlled trial enrolled people with biopsy-confirmed NASH, stage 1 to 3 fibrosis, body mass index above 25 kg/m2 (the overweight threshold), HbA1c at or below 10% and NAFLD Activity Score at or above 4

We will work with you to discuss your needs and develop and individualized treatment plan

2023 Sep 7;389(10):877-888